The patients who require insulin therapy are more prone than other T2DM patients to atherosclerotic cardiovascular disease because of their advanced disease status and poorly controlled hyperglycemia and because the insulin therapy itself elevates the risk of atherosclerosis. Here, INS is linked to atherosclerosis.